-
1
-
-
0035927982
-
Respiratory syncytial virus and parainfluenza virus
-
Hall C.B. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344:2001;1917-1928.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 1917-1928
-
-
Hall, C.B.1
-
2
-
-
0036425594
-
What have we learned from the Tucson Children's Respiratory Study
-
Martinez F. What have we learned from the Tucson Children's Respiratory Study. Paediatr. Respir. Rev. 3:2002;193-197.
-
(2002)
Paediatr. Respir. Rev.
, vol.3
, pp. 193-197
-
-
Martinez, F.1
-
3
-
-
0036419092
-
A cohort of children hospitalized with acute RSV bronchiolitis: Impact on later respiratory disease
-
Sigurs N. A cohort of children hospitalized with acute RSV bronchiolitis: impact on later respiratory disease. Paediatr. Respir. Rev. 3:2002;177-183.
-
(2002)
Paediatr. Respir. Rev.
, vol.3
, pp. 177-183
-
-
Sigurs, N.1
-
4
-
-
0032926030
-
Respiratory syncytial virus pneumonia among the elderly: An assessment of disease burden
-
Han L.L., Alexander J.P., Anderson L.J. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J. Inf. Dis. 179:1999;25-30.
-
(1999)
J. Inf. Dis.
, vol.179
, pp. 25-30
-
-
Han, L.L.1
Alexander, J.P.2
Anderson, L.J.3
-
5
-
-
0033949819
-
Respiratory syncytial virus infection in adults
-
Falsey A.R., Walsh E.E. Respiratory syncytial virus infection in adults. Clin. Microbiol. Rev. 13:2000;371-384.
-
(2000)
Clin. Microbiol. Rev.
, vol.13
, pp. 371-384
-
-
Falsey, A.R.1
Walsh, E.E.2
-
6
-
-
0037054037
-
Winter viruses: Influenza- and respiratory syncytial virus-related morbidity in chronic lung disease
-
Griffin M.R., Coffey C.S., Neuzil K.M., Mitchel E.F. Jr., Wright P.F., Edwards K.M. Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. Arch. Intern. Med. 162:2002;1229-1236.
-
(2002)
Arch. Intern. Med.
, vol.162
, pp. 1229-1236
-
-
Griffin, M.R.1
Coffey, C.S.2
Neuzil, K.M.3
Mitchel E.F., Jr.4
Wright, P.F.5
Edwards, K.M.6
-
7
-
-
0014493282
-
An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children vaccinated with an inactivated RS virus vaccine
-
Kapikian A.Z., Mitchell R.H., Chanock R.M., Shevdoff R.A., Stewart C.E. An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:1968;405-413.
-
(1968)
Am. J. Epidemiol
, vol.89
, pp. 405-413
-
-
Kapikian, A.Z.1
Mitchell, R.H.2
Chanock, R.M.3
Shevdoff, R.A.4
Stewart, C.E.5
-
8
-
-
0014495251
-
Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
-
Kim H.W., Canchola J.G., Brandt C.D.et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:1969;422-434.
-
(1969)
Am. J. Epidemiol.
, vol.89
, pp. 422-434
-
-
Kim, H.W.1
Canchola, J.G.2
Brandt, C.D.3
-
9
-
-
0026460748
-
Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells
-
Connors M., Kulkarni A.B., Firestone C.Y., Holmes K.L., Morse H.C. III, Sotnikov A.V.et al. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol. 66:1992;7444-7451.
-
(1992)
J. Virol
, vol.66
, pp. 7444-7451
-
-
Connors, M.1
Kulkarni, A.B.2
Firestone, C.Y.3
Holmes, K.L.4
Morse H.C. III5
Sotnikov, A.V.6
-
10
-
-
0037120001
-
A role for immune complexes in enhanced respiratory syncytial virus disease
-
Polack F.P., Teng M.N., Collins P.L.et al. A role for immune complexes in enhanced respiratory syncytial virus disease. J. Exp. Med. 196:2002;859-865.
-
(2002)
J. Exp. Med.
, vol.196
, pp. 859-865
-
-
Polack, F.P.1
Teng, M.N.2
Collins, P.L.3
-
11
-
-
0031848862
-
Respiratory syncytial virus vaccines
-
Dudas R.A., Karron R.A. Respiratory syncytial virus vaccines. Clin. Microbiol Rev. 11:1998;430-439.
-
(1998)
Clin. Microbiol Rev.
, vol.11
, pp. 430-439
-
-
Dudas, R.A.1
Karron, R.A.2
-
12
-
-
0032623340
-
Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics
-
Collins P.L., Whitehead S.S., Bukreyev A.et al. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Adv. Virus Res. 54:1999;423-451.
-
(1999)
Adv. Virus Res.
, vol.54
, pp. 423-451
-
-
Collins, P.L.1
Whitehead, S.S.2
Bukreyev, A.3
-
13
-
-
0029817240
-
Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein or respiratory syncytial virus
-
Hancock G.E., Speelman D.J., Heers K., Bortell E., Smith J., Cosco C. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein or respiratory syncytial virus. J. Virol. 70:1996;7783-7791.
-
(1996)
J. Virol.
, vol.70
, pp. 7783-7791
-
-
Hancock, G.E.1
Speelman, D.J.2
Heers, K.3
Bortell, E.4
Smith, J.5
Cosco, C.6
-
14
-
-
0028902386
-
Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection
-
Hancock G.E., Speelman D.J., Frenchick P.J., Mineo-Kuhn M.M., Baggs R.B., Hahn D.J. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection. Vaccine. 13:1995;391-400.
-
(1995)
Vaccine
, vol.13
, pp. 391-400
-
-
Hancock, G.E.1
Speelman, D.J.2
Frenchick, P.J.3
Mineo-Kuhn, M.M.4
Baggs, R.B.5
Hahn, D.J.6
-
15
-
-
0027402921
-
Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins
-
Alwan W.H., Openshaw P.J. Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine. 11:1993;431-437.
-
(1993)
Vaccine
, vol.11
, pp. 431-437
-
-
Alwan, W.H.1
Openshaw, P.J.2
-
16
-
-
0035860575
-
CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)
-
Hancock G.E., Heers K.M., Smith J.D., Scheuer C.A., Ibraghimov A.R., Pryharski K.S. CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV). Vaccine. 19:2001;4874-4882.
-
(2001)
Vaccine
, vol.19
, pp. 4874-4882
-
-
Hancock, G.E.1
Heers, K.M.2
Smith, J.D.3
Scheuer, C.A.4
Ibraghimov, A.R.5
Pryharski, K.S.6
-
17
-
-
0036521725
-
Toll-like receptor 9 mediates CpG-DNA signaling
-
Chuang T.H., Lee J., Kline L., Mathison J.C., Ulevitch R.J. Toll-like receptor 9 mediates CpG-DNA signaling. J. Leukoc Biol. 71:2002;538-544.
-
(2002)
J. Leukoc Biol
, vol.71
, pp. 538-544
-
-
Chuang, T.H.1
Lee, J.2
Kline, L.3
Mathison, J.C.4
Ulevitch, R.J.5
-
18
-
-
0036604930
-
Control of adaptive immune responses by Toll-like receptors
-
Barton G.M., Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:2002;380-383.
-
(2002)
Curr. Opin. Immunol
, vol.14
, pp. 380-383
-
-
Barton, G.M.1
Medzhitov, R.2
-
19
-
-
0033580949
-
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
-
Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:1999;17406-17409.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 17406-17409
-
-
Schwandner, R.1
Dziarski, R.2
Wesche, H.3
Rothe, M.4
Kirschning, C.J.5
-
20
-
-
0035909372
-
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3
-
Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:2001;732-738.
-
(2001)
Nature
, vol.413
, pp. 732-738
-
-
Alexopoulou, L.1
Holt, A.C.2
Medzhitov, R.3
Flavell, R.A.4
-
21
-
-
0033120081
-
Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the LPS gene product
-
Hoshino K., Takeuchi O., Kawai T.et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162:1999;3749-3752.
-
(1999)
J. Immunol
, vol.162
, pp. 3749-3752
-
-
Hoshino, K.1
Takeuchi, O.2
Kawai, T.3
-
22
-
-
0028089006
-
The pulmonary immune response of BALB/c mice vaccinated with the fusion protein of respiratory syncytial virus
-
Hancock G.E., Hahn D.J., Speelman D.J., Hildreth S.W., Pillai S., McQueen K. The pulmonary immune response of BALB/c mice vaccinated with the fusion protein of respiratory syncytial virus. Vaccine. 12:1994;267-274.
-
(1994)
Vaccine
, vol.12
, pp. 267-274
-
-
Hancock, G.E.1
Hahn, D.J.2
Speelman, D.J.3
Hildreth, S.W.4
Pillai, S.5
McQueen, K.6
-
23
-
-
0032890867
-
Respiratory syncytial virus infection: Immune response, immunopathogenesis, and treatment
-
Domachowske J.B., Rosenberg H.F. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin. Microbiol. Rev. 12:1999;298-309.
-
(1999)
Clin. Microbiol. Rev.
, vol.12
, pp. 298-309
-
-
Domachowske, J.B.1
Rosenberg, H.F.2
-
24
-
-
0036065808
-
Further checkpoints in Th1 development
-
Robinson D.S., O'Garra A. Further checkpoints in Th1 development. Immunity. 16:2002;755-758.
-
(2002)
Immunity
, vol.16
, pp. 755-758
-
-
Robinson, D.S.1
O'Garra, A.2
-
25
-
-
0034098957
-
The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12
-
Hancock G.E., Smith J.D., Heers K.M. The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12. Viral Immunol. 13:2000;57-72.
-
(2000)
Viral Immunol
, vol.13
, pp. 57-72
-
-
Hancock, G.E.1
Smith, J.D.2
Heers, K.M.3
-
26
-
-
0031181334
-
IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness
-
Hussell T., Khan U., Openshaw P.J.M. IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness. J. Immunol. 159:1997;328.
-
(1997)
J. Immunol.
, vol.159
, pp. 328
-
-
Hussell, T.1
Khan, U.2
Openshaw, P.J.M.3
-
27
-
-
0029099861
-
Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity
-
Tang Y.W., Graham B.S. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J. Infect. Dis. 172:1995;734.
-
(1995)
J. Infect. Dis.
, vol.172
, pp. 734
-
-
Tang, Y.W.1
Graham, B.S.2
-
28
-
-
0023707741
-
Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies
-
Anderson L.J., Bingham P., Hierholzer J.C. Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J. Virol. 62:1988;4232-4238.
-
(1988)
J. Virol.
, vol.62
, pp. 4232-4238
-
-
Anderson, L.J.1
Bingham, P.2
Hierholzer, J.C.3
-
29
-
-
0034080129
-
The serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines co-formulated with natural fusion and attachment proteins of respiratory syncytial virus
-
Hancock G.E., Smith J.D., Heers K.M. The serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines co-formulated with natural fusion and attachment proteins of respiratory syncytial virus. J. Inf. Dis. 181:2000;1768-1771.
-
(2000)
J. Inf. Dis.
, vol.181
, pp. 1768-1771
-
-
Hancock, G.E.1
Smith, J.D.2
Heers, K.M.3
-
30
-
-
0034507382
-
QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus
-
Hancock G.E., Heers K.M., Smith J.D. QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus. Viral Immunol. 13:2000;503-509.
-
(2000)
Viral Immunol
, vol.13
, pp. 503-509
-
-
Hancock, G.E.1
Heers, K.M.2
Smith, J.D.3
-
31
-
-
0037018097
-
Adjuvants of immunity: Harnessing innate immunity to promote adaptive immunity
-
Bendelac A., Medzhitov R. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J. Exp. Med. 4(195):2002;F19-F23.
-
(2002)
J. Exp. Med.
, vol.4
, Issue.195
-
-
Bendelac, A.1
Medzhitov, R.2
-
32
-
-
0034775153
-
Toll-like receptors control activation of adaptive immune responses
-
Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:2001;947-950.
-
(2001)
Nat. Immunol.
, vol.2
, pp. 947-950
-
-
Schnare, M.1
Barton, G.M.2
Holt, A.C.3
Takeda, K.4
Akira, S.5
Medzhitov, R.6
-
33
-
-
0024410891
-
Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice
-
Coffman R.L., Seymour B.W.P., Hudak S., Jackson J., Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 245:1989;308-310.
-
(1989)
Science
, vol.245
, pp. 308-310
-
-
Coffman, R.L.1
Seymour, B.W.P.2
Hudak, S.3
Jackson, J.4
Rennick, D.5
-
34
-
-
0025216937
-
Lymphokine control of in vivo immunoglobulin isotype selection
-
Finkleman F.D., Holmes J., Katona I.M.et al. Lymphokine control of in vivo immunoglobulin isotype selection. Ann. Rev. Immunol. 8:1990;303.
-
(1990)
Ann. Rev. Immunol
, vol.8
, pp. 303
-
-
Finkleman, F.D.1
Holmes, J.2
Katona, I.M.3
-
35
-
-
0037083298
-
Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals
-
de Jong E.C., Vieira P.L., Kalinski P.et al. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 168:2002;1704-1709.
-
(2002)
J. Immunol
, vol.168
, pp. 1704-1709
-
-
De Jong, E.C.1
Vieira, P.L.2
Kalinski, P.3
-
36
-
-
5944261457
-
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
-
Kurt-Jones E.A., Popova L., Kwinn L.et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:2000;398-401.
-
(2000)
Nat. Immunol.
, vol.1
, pp. 398-401
-
-
Kurt-Jones, E.A.1
Popova, L.2
Kwinn, L.3
-
37
-
-
0036164902
-
Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug
-
Oberholzer A., Oberholzer C., Moldawer L.L. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit. Care Med. 30:2002;S58-S63.
-
(2002)
Crit. Care Med.
, vol.30
-
-
Oberholzer, A.1
Oberholzer, C.2
Moldawer, L.L.3
-
38
-
-
0031573220
-
Analysis of granuloma formation in double cytokine-deficient mice reveals a central role forIL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo
-
Wynn T.A., Morawetz R., Scharton-Kersten T.et al. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role forIL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J. Immunol. 159:1997;5014-5023.
-
(1997)
J. Immunol.
, vol.159
, pp. 5014-5023
-
-
Wynn, T.A.1
Morawetz, R.2
Scharton-Kersten, T.3
-
39
-
-
0035961452
-
Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease
-
Prince G.A., Denamur F., Deschamps M.et al. Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease. Vaccine. 19:2001;2048-2054.
-
(2001)
Vaccine
, vol.19
, pp. 2048-2054
-
-
Prince, G.A.1
Denamur, F.2
Deschamps, M.3
|